Axel Bolte

2020

In 2020, Axel Bolte earned a total compensation of $5.4M as President and Chief Executive Officer at Inozyme Pharma, a 452% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$290,466
Option Awards$4,584,236
Salary$440,099
Other$40,833
Total$5,355,634

Bolte received $4.6M in option awards, accounting for 86% of the total pay in 2020.

Bolte also received $290.5K in non-equity incentive plan, $440.1K in salary and $40.8K in other compensation.

Rankings

In 2020, Axel Bolte's compensation ranked 2,024th out of 13,090 executives tracked by ExecPay. In other words, Bolte earned more than 84.5% of executives.

ClassificationRankingPercentile
All
2,024
out of 13,090
85th
Division
Manufacturing
781
out of 5,618
86th
Major group
Chemicals And Allied Products
279
out of 2,251
88th
Industry group
Drugs
235
out of 1,951
88th
Industry
Pharmaceutical Preparations
165
out of 1,456
89th
Source: SEC filing on April 27, 2021.

Bolte's colleagues

We found two more compensation records of executives who worked with Axel Bolte at Inozyme Pharma in 2020.

2020

Pedro Huertas

Inozyme Pharma

Chief Medical Officer

2020

Henric Bjarke

Inozyme Pharma

Chief Operating Officer

News

In-depth

You may also like